Literature DB >> 23481621

Smoking, surgery, and venous thromboembolism risk in women: United Kingdom cohort study.

Siân Sweetland1, Lianne Parkin, Angela Balkwill, Jane Green, Gillian Reeves, Valerie Beral.   

Abstract

BACKGROUND: Evidence about the effect of smoking on venous thromboembolism risk, generally and in the postoperative period, is limited and inconsistent. We examined the incidence of venous thromboembolism in relation to smoking habits, both in the absence of surgery and in the first 12 postoperative weeks, in a large prospective study of women in the United Kingdom. METHODS AND
RESULTS: During 6 years' follow-up of 1 162 718 women (mean age 56 years), 4630 were admitted to hospital for or died of venous thromboembolism. In the absence of surgery, current smokers had a significantly increased incidence of venous thromboembolism compared with never-smokers (adjusted relative risk 1.38, 95% confidence interval 1.28-1.48), with significantly greater risks in heavier than lighter smokers (relative risks 1.47 [95% confidence interval 1.34-1.62] and 1.29 [95% confidence interval 1.17-1.42] for ≥15 versus <15 cigarettes per day). Current smokers were also more likely to have surgery than never-smokers (relative risk 1.12, 95% confidence interval 1.12-1.13). Among women who had surgery, the incidence of venous thromboembolism in the first 12 postoperative weeks was significantly greater in current than never-smokers (relative risk 1.16, 95% confidence interval 1.02-1.30).
CONCLUSIONS: Venous thromboembolism incidence was increased in current smokers, both in the absence of surgery and in the 12 weeks after surgery. Smoking is another factor to consider in the assessment of venous thromboembolism risk in patients undergoing surgery.

Entities:  

Mesh:

Year:  2013        PMID: 23481621     DOI: 10.1161/CIRCULATIONAHA.113.001428

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  11 in total

1.  Heart disease and stroke statistics--2014 update: a report from the American Heart Association.

Authors:  Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2013-12-18       Impact factor: 29.690

Review 2.  Progress in the research on venous thromboembolism.

Authors:  Zhen Zhang; Liang Tang; Yu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

Review 3.  Epidemiology of venous thromboembolism.

Authors:  John A Heit
Journal:  Nat Rev Cardiol       Date:  2015-06-16       Impact factor: 32.419

Review 4.  The epidemiology of venous thromboembolism.

Authors:  John A Heit; Frederick A Spencer; Richard H White
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

5.  Association of smoking and cancer with the risk of venous thromboembolism: the Scandinavian Thrombosis and Cancer cohort.

Authors:  Benedikte Paulsen; Olga V Gran; Marianne T Severinsen; Jens Hammerstrøm; Søren R Kristensen; Suzanne C Cannegieter; Hanne Skille; Anne Tjønneland; Frits R Rosendaal; Kim Overvad; Inger Anne Næss; John-Bjarne Hansen; Sigrid K Brækkan
Journal:  Sci Rep       Date:  2021-09-21       Impact factor: 4.379

Review 6.  Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis.

Authors:  Yun-Jiu Cheng; Zhi-Hao Liu; Feng-Juan Yao; Wu-Tao Zeng; Dong-Dan Zheng; Yu-Gang Dong; Su-Hua Wu
Journal:  PLoS Med       Date:  2013-09-17       Impact factor: 11.069

7.  Serum uric acid is associated with increased risk of idiopathic venous thromboembolism in high HDL-C population: A case-control study.

Authors:  Miao Yu; Ken Ling; Yunfei Teng; Qin Li; Fei Mei; Yiqing Li; Chenxi Ouyang
Journal:  Exp Ther Med       Date:  2016-04-05       Impact factor: 2.447

8.  Antidepressants, Depression, and Venous Thromboembolism Risk: Large Prospective Study of UK Women.

Authors:  Lianne Parkin; Angela Balkwill; Siân Sweetland; Gillian K Reeves; Jane Green; Valerie Beral
Journal:  J Am Heart Assoc       Date:  2017-05-17       Impact factor: 5.501

9.  Risk Factors for Chemotherapy-Associated Venous Thromboses in Gynaecological Oncology Patients.

Authors:  Sandra Nezi-Cahn; Isabel Sicking; Kathrin Almstedt; Marco Battista; Anne-Sophie Heimes; Slavomir Krajnak; Joscha Steetskamp; Annette Hasenburg; Marcus Schmidt
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-06-05       Impact factor: 2.915

10.  Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data.

Authors:  Philip Mease; Christina Charles-Schoeman; Stanley Cohen; Lara Fallon; John Woolcott; Huifeng Yun; Joel Kremer; Jeffrey Greenberg; Wendi Malley; Alina Onofrei; Keith S Kanik; Daniela Graham; Cunshan Wang; Carol Connell; Hernan Valdez; Manfred Hauben; Eric Hung; Ann Madsen; Thomas V Jones; Jeffrey R Curtis
Journal:  Ann Rheum Dis       Date:  2020-08-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.